Skip to main content
MEHA
OTC Life Sciences

Functional Brands Terminates $142.9M BullionFX Acquisition, Avoiding Massive Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Positive
Importance info
10
Price
$0.005
Mkt Cap
$222.264K
52W Low
$0.005
52W High
$8
52W Position info
4.0% above low
Off High info
100% below high
Rel. Volume
Market data snapshot near publication time

MEHA is trading near its 52-week low of $0.005 (4.0% above the low).

Summary

Functional Brands Inc. has terminated its highly dilutive $142.9 million acquisition of BullionFX's Alchemy assets, preventing further financial strain and dilution for the micro-cap company.


Key Events · M&A and Partnerships · MEHA

  • Acquisition Agreement Terminated

    Functional Brands Inc. announced the termination of its Asset Purchase Agreement with BullionFX, effective June 29, 2026.

  • Avoids Significant Dilution

    The termination prevents the issuance of 100,000 shares of Series D Convertible Preferred Stock, which was the consideration for the $142.9 million acquisition.

  • Removes Major Financial Overhang

    This decision removes a substantial financial obligation and potential dilution that was disproportionate to the company's current market capitalization and financial health.

  • Context of Delisting

    This event occurs shortly after the company received a Nasdaq Staff Delisting Determination, highlighting its severe financial challenges.


Analysis · MEHA · Life Sciences

Functional Brands Inc. has terminated its definitive agreement to acquire BullionFX's Alchemy assets. This acquisition, previously valued at $142.9 million and involving the issuance of 100,000 shares of Series D Convertible Preferred Stock, was highly dilutive and significantly larger than the company's current market capitalization. The termination removes a major financial obligation and prevents immediate, substantial dilution for existing shareholders, which is a critical development given the company's ongoing financial distress, recent Nasdaq delisting, and current stock price trading near its 52-week low.

At the time of this filing, MEHA was trading at $0.01 on OTC in the Life Sciences sector, with a market capitalization of approximately $222.3K. The 52-week trading range was $0.01 to $8.00. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0043
Real-time Price: $0.0044 info
Change: +$0.0001 (+2%) info
Market Cap: $185.709K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0416
Real-time Price: $0.0044 info
Change: -$0.0372 (-89%) info
Market Cap: $185.709K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
Price at Filing: $0.038
Real-time Price: $0.0044 info
Change: -$0.0336 (-88%) info
Market Cap: $185.709K info
MEHA
Jun 05, 2026, 2:29 PM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.0722
Real-time Price: $0.0044 info
Change: -$0.0678 (-94%) info
Market Cap: $185.709K info
MEHA
Jun 04, 2026, 9:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.0682
Real-time Price: $0.0044 info
Change: -$0.0638 (-94%) info
Market Cap: $185.709K info